FOLKEHELSEINSTITUTTET

Their core work

The Norwegian Institute of Public Health (NIPH) is Norway's central institution for public health research, disease surveillance, and population health monitoring. They specialize in large-scale epidemiological studies tracking how environmental exposures — chemicals, air pollution, diet, and infectious agents — affect human health across the lifespan, from pregnancy through old age. NIPH manages major birth cohorts and biomonitoring programs, providing critical data infrastructure for European health research. They also lead national and European efforts in vaccine effectiveness monitoring, pandemic preparedness, and chronic disease prevention policy.

What they specialise in

How they've shifted over time

In the early H2020 period (2015–2018), NIPH focused on established public health themes: clinical decision support (GUIDES), brain imaging cohorts (Lifebrain), human biomonitoring of chemical exposures (HBM4EU), and traditional vaccine monitoring (I-MOVE-plus). From 2019 onward, their portfolio pivoted sharply toward two areas: the exposome concept — integrating all environmental, chemical, and lifestyle exposures into unified health models (ATHLETE, HEDIMED, EXIMIOUS) — and rapid pandemic response infrastructure (RECoVER, EU-RESPONSE, VACCELERATE, PHIRI). The recent period also shows growing involvement in computational toxicology and AI-driven risk assessment (ONTOX), suggesting a move toward data-intensive, predictive approaches to public health.

NIPH is converging on data-driven exposure science — combining birth cohorts, omics, AI toxicology, and environmental monitoring — positioning them as a go-to partner for any project linking environmental factors to population health outcomes.

How they like to work

NIPH operates primarily as an active partner (24 of 30 projects), contributing deep epidemiological data and cohort access rather than leading consortia. When they do coordinate (5 projects including CO-CREATE at EUR 2M and INFERTILITY at EUR 1.5M), it tends to be in areas where they hold unique population data assets. With 511 unique partners across 59 countries, they function as a well-connected hub in European health research — valuable for consortium builders who need a credible Nordic partner with extensive network reach.

NIPH has collaborated with 511 distinct organizations across 59 countries, making them one of the most broadly networked public health institutes in Europe. Their partnerships span well beyond the Nordic region, covering major research institutions across all EU member states and extending into global health networks.

What sets them apart

NIPH's key differentiator is their combination of national-scale population data (Norwegian birth cohorts, health registries, biobanks) with deep European collaboration networks. Few institutes can offer both longitudinal cohort data spanning decades and the epidemiological expertise to analyze it at population level. For consortium builders, NIPH brings not just scientific credibility but access to some of the world's most complete health registries — a resource that cannot be replicated and that strengthens any proposal involving life-course health research.

Highlights from their portfolio

• ATHLETE
  Largest single grant (EUR 2.1M to NIPH) — a flagship exposome project integrating environmental pollutants, pregnancy data, and childhood health across multiple European cohorts.
• CO-CREATE
  NIPH's largest coordinated project (EUR 2.1M) bringing youth into obesity policy design — demonstrates their ability to lead interdisciplinary, policy-oriented research.
• ONTOX
  Signals NIPH's expansion into AI-driven toxicology and animal-free chemical testing (EUR 1.2M), a rapidly growing regulatory science field.